AMN HEALTHCARE SERVICES INCAMN
ASignal's systematic analysis rates AMN as Neutral.
Reflects the latest available analysis · analyzed Sep 17, 2026
The case on AMN
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Free cash flow of $445.77M indicates strong cash generation
- EV/Revenue of 0.51x suggests below-market valuation relative to sales
- Price-to-sales of 0.39x is low, indicating potential undervaluation
- Return on Equity of 15.56% reflects solid capital efficiency
- Low beta of 0.39x indicates below-market volatility and defensive characteristics
- Debt-to-equity ratio of 1.05x is elevated, above the 1.0 threshold
- Revenue growth of 2.30% is weak, indicating limited top-line momentum
- Forward P/E of 37.28x is high relative to current earnings and growth
- MACD below signal line with negative histogram suggests weakening momentum
- No Reddit mentions, indicating low retail investor interest or visibility
See the full verdict on AMN
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes AMN
Most investors never get a second opinion, let alone several. ASignal runs AMN past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.